Lanthio Pharma, MorphoSys deal

MorphoSys exercised its option under a 2012 deal to purchase Lanthio’s lanthipeptide technology for drug discovery. LanthioPep uses the Lactococcus lactis bacterium to generate lantipeptides, which ar...